Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What is Metabolism?00:52

What is Metabolism?

131.2K
Overview
131.2K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

869
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
869
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

550
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
550
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

959
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
959
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

489
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
489

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-uniform growth probability of Mycobacterium tuberculosis across inoculum densities partially restored by culture filtrate: Implications for supplemented growth assays.

Journal of microbiological methods·2026
Same author

Guanilated Quinolones with Dual Antitubercular and Anti-Inflammatory Activities.

ChemMedChem·2026
Same author

Beyond Inhibition: Sublethal Rifampicin-Induced Molecular Adaptations Confer Phenotypic Drug Tolerance in Mycobacteria.

ACS infectious diseases·2026
Same author

Novel, Achiral 4‑Nitroimidazole Compounds with Potent Antitubercular Activity.

ACS omega·2026
Same author

Cobamide metabolism, regulation, and adaptation in <i>Mycobacterium tuberculosis</i>.

Journal of bacteriology·2025
Same author

Disruption of riboflavin biosynthesis in mycobacteria establishes riboflavin pathway intermediates as key precursors of MAIT cell agonists.

PLoS pathogens·2025
Same journal

Structures of the endophytic microbiota during heart rot development in <i>Abies georgei</i> var. <i>smithii</i>.

Microbiology spectrum·2026
Same journal

High <i>Yersinia</i> prevalence in tonsils of wild boars hunted in Northeast Germany using a novel protocol including long cold enrichment.

Microbiology spectrum·2026
Same journal

Genetic variation, recombinant characteristics, and seroprevalence analysis of echovirus 3 causing severe and mild cases of hand, foot, and mouth disease in Guizhou Province.

Microbiology spectrum·2026
Same journal

Mycelial morphology influenced aerobic DNRA in <i>Streptomyces mediolani</i> EM-B2: short rod-shaped mycelium showed markedly greater efficiency than long filamentous mycelium.

Microbiology spectrum·2026
Same journal

Performance and practicality of 16S nanopore sequencing for routine bacterial identification in clinical samples.

Microbiology spectrum·2026
Same journal

Molecular characterization and correlation with β-lactam resistance of penicillin-binding protein2x, 2b, and 1a of <i>Streptococcus pneumoniae</i> in clinical pneumococcal isolates.

Microbiology spectrum·2026
See all related articles

Related Experiment Video

Updated: Jan 21, 2026

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence
10:06

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence

Published on: February 26, 2018

7.8K

Mycobacterium tuberculosis Metabolism.

Gabriel T Mashabela1,2, Timothy J de Wet1,3, Digby F Warner1,4

  • 1SAMRC/NHLS/UCT Molecular Mycobacteriology Research Unit, DST/NRF Centre of Excellence for Biomedical TB Research, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa.

Microbiology Spectrum
|July 28, 2019
PubMed
Summary
This summary is machine-generated.

Mycobacterium tuberculosis (TB) has unique metabolic adaptations for human host survival. Understanding these metabolic pathways is crucial for developing new anti-TB drugs and combating the disease.

More Related Videos

Separation and Fractionation of Culture Filtrate Proteins (CFPs) from Mycobacterium tuberculosis
08:48

Separation and Fractionation of Culture Filtrate Proteins (CFPs) from Mycobacterium tuberculosis

Published on: July 11, 2025

559
An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
09:02

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei

Published on: February 17, 2014

20.2K

Related Experiment Videos

Last Updated: Jan 21, 2026

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence
10:06

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence

Published on: February 26, 2018

7.8K
Separation and Fractionation of Culture Filtrate Proteins (CFPs) from Mycobacterium tuberculosis
08:48

Separation and Fractionation of Culture Filtrate Proteins (CFPs) from Mycobacterium tuberculosis

Published on: July 11, 2025

559
An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
09:02

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei

Published on: February 17, 2014

20.2K

Area of Science:

  • Microbiology
  • Pathogen Metabolism
  • Host-Pathogen Interactions

Background:

  • Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains a global health challenge despite existing treatments and vaccines.
  • M. tuberculosis exhibits a broad metabolic repertoire, suggesting adaptation and augmentation of ancestral pathways for host persistence.

Purpose of the Study:

  • To elucidate M. tuberculosis metabolic functions under disease-relevant conditions.
  • To understand host-pathogen coevolution and M. tuberculosis adaptations within the human host.

Main Methods:

  • Review of recent advances in mycobacterial metabolic function.
  • Analysis of M. tuberculosis metabolic innovations in the context of host infection.
  • Consideration of host-pathogen coevolutionary framework.

Main Results:

  • M. tuberculosis possesses unusual metabolic adaptations distinct from other model intracellular pathogens.
  • These metabolic "innovations" impact susceptibility to current and experimental anti-TB drugs.

Conclusions:

  • Elucidating M. tuberculosis metabolism is key to understanding pathogenicity.
  • Targeting specific metabolic pathways presents a promising strategy for novel anti-TB drug development.
  • Further research into fundamental mycobacterial metabolism is needed to address knowledge gaps.